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Abstract 
 
ESAC, the EURL ECVAM Scientific Advisory Committee, advises EURL ECVAM on scientific 
issues. Its main role is to conduct independent peer review of validation studies of 
alternative test methods and to assess their scientific validity for a given purpose. The 
committee reviews the appropriateness of study design and management, the quality of 
results obtained and the plausibility of the conclusions drawn. ESAC peer reviews are 
formally initiated with a EURL ECVAM Request for ESAC Advice, which provides the 
necessary background for the peer-review and establishes its objectives, timelines and 
the questions to be addressed. The peer review is normally prepared by specialised ESAC 
Working Groups. These are typically composed of ESAC members and other external 
experts relevant to the test method under review. These experts may be nominated by 
ESAC, EURL ECVAM and partner organisations within the International Cooperation on 
Alternative Test Methods (ICATM). ESAC ultimately decides on the composition of these 
Working Groups. ESAC's advice to EURL ECVAM is formally provided as 'ESAC Opinions' 
and 'Working Group Reports' at the end of the peer review. ESAC may also issue 
Opinions on other scientific issues of relevance to the work and mission of EURL ECVAM 
but not directly related to a specific alternative test method.   
The ESAC Opinion expressed in this report relates to the use of Performance Standards 
to evaluate test methods similar to a Validated Reference Method. 
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Ispra, 24 June 2016 
ESAC Opinion 
 
At the 42nd meeting of the EURL ECVAM Scientific Advisory Committee (ESAC) (Annex 1), 
two in vitro toxicology methods were evaluated according to the published OECD 
Performance Standards (OECD, 2015a, b). In the discussion several issues came to light 
which are generic in nature and concern the general approach to Performance Standards. 
The "Performance Standards" approach has four main objectives: 
1. To allow competition between developers of test methods. 
2. To encourage the development of "me too/generic" test methods. 
3. To ensure that these "me too/ generic" methods, perform equally as well as the 
original, fully validated method. 
4. To allow the evaluation of the performance of these "me too" methods to be more 
efficient and less costly than a full validation. 
ESAC fully supports these aims which it believes can be achieved, as intended, but 
requires a different approach to evaluating the data, viz.  
While power calculations have identified that full validation studies require more than 50 
chemicals to be evaluated in order to calculate sensitivity and specificity and hence 
accuracy with satisfactory precision, these cannot be meaningfully calculated with e.g. 10 
negative and 10 positive reference chemicals as proposed in the OECD Series on Testing 
and Assessment No. 220 (OECD, 2015b). The 95 %-Confidence Interval for a specificity 
of 8/10 = 80 % observed in the "Performance Standards" approach ranges from 44 % to 
97 %. From this it can be seen that there is insufficient statistical power to evaluate a 
new test method's performance using this measure. 
The same is true of comparing within and between laboratory reproducibility where the 
sample size is equally small. 
As the reference chemicals proposed in Performance Standards to evaluate "me too/ 
generic" test methods will have been used in the validation of the reference method(s), it 
seems more useful to assess equivalence of a new method with the reference method(s), 
side by side, on the basis of the predictions for the individual reference chemicals instead 
of comparing sensitivity, specificity and accuracy to prespecified threshold values. It is, 
e.g. possible that two methods meet the performance standards of 80 % for sensitivity, 
specificity and accuracy, but disagree on 4 of the 20 reference chemicals (this would 
correspond to a Fleiss Kappa value of 0.6, indicating only moderate agreement between 
the methods).  
It should be possible in the Performance Standards instead to specify the maximum 
number of different results allowed if the method is considered to be equivalent. 
Scientific judgment should be used in examining and concluding on these differences. For 
example, one method may have discordant runs with a majority of runs positive for a 
given endpoint and for the same test chemical the other method has discordant runs with 
the majority negative. The fact that the result was based on discordant runs in both 
cases might suggest that there was no real difference between the methods. 
More flexibility in the application of the Performance Standards would be helpful in 
obtaining more meaningful results, for example:  
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Provision should be made to exclude from the maximum permitted number of five 
independent tests per reference chemical those tests included in non-qualified runs that 
occur due to failure of the Positive or Negative Controls; and/or due to technical issues 
that are legitimately identified whilst conducting the test run (e.g. obvious chemical or 
microbiological contamination), provided that the testing is then stopped and the run 
abandoned at that point. If such a provision is included in the Performance Standards, 
then a maximum permitted number of non-qualified runs should also be defined. 
However, in some situations, less flexibility is warranted. In order to have confidence in 
the conclusions of such evaluations, ESAC believes it is important to have more rigorous 
enforcement with respect to the use of different chemical sets to develop and optimise 
the test method, for training and proficiency testing, and for ring-trial reference 
chemicals. 
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